NCT06549725Recruiting
Clinical Performance of Medical Device Software "Lipidica 1.0" for Processing Data Generated by Lipidomic Analysis in Pancreatic Cancer Screening
Source: ClinicalTrials.gov · Last updated 27 Apr 2026
Brief summary (registry, in English)
Software "Lipidica" is intended to be used for processing data generated by the in-house in vitro diagnostic medical device for lipidomic testing for the purpose of screening Pancreatic cancer (PaC) in the population at high risk of this cancer due to familial risk, selected gene mutations or hereditary pancreatic diseases. The primary objective is to verify that the investigational IVDSW can discriminate between results of patients with Pancreatic cancer and persons without Pancreatic cancer but at higher risk of this cancer disease due to their predispositions. Participants will: * come to baseline and end of study visit for blood sampling and medical imaging * some participant will undertake one more visit depending on their results on baseline
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 419 (estimated)
- First submitted
- 5 Aug 2024
- Start date
- 10 Sept 2024
- Primary completion date
- 26 Sept 2027
- Lead sponsor
- Lipidica, a.s.
- Diseases
- Pancreatic cancer
- NCT number
- NCT06549725
What you commit to
- Study type: Interventional
- Planned participants: 419
- From 10 Sept 2024 to the primary completion date, 26 Sept 2027
- 16 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Unfit for radical curative resection of the tumor
Other illness
- History of any other cancer disease
- Present incurable malignancy
- History of any cancer disease
- Present incurable malignancy
Other
- Vegan or vegetarian diet
- Pregnancy of planning to conceive in the next 12 months
- Inability to undergo planned medical imaging or blood sampling
- Vegan or vegetarian diet
Who the study is looking for
- Age ≥ 18 years
- Signed informed consent
- Histologically confirmed diagnosis of resectable PaC
- Age ≥ 18 years
- Signed informed consent
- High risk of PaC due to the presence of one of the following risk factors:
- Family history of PaC (≥ 2 first-degree or second-degree relatives with PaC in the same family line)
- Confirmed germline mutation of STK11 (LKB1) regardless of family history
- Confirmed germline mutation of CDKN2A leading to the alteration of p16 regardless of family history
- Confirmed germline mutation of APC, ATM, BRCA1, BRCA2, MLH1, MSH2, MSH6, PMS2, EPCAM, PALB2 or TP53 AND ≥ 1 first-degree or second-degree relative with PaC
- Present hereditary pancreatitis (recurrent acute pancreatitis or chronic pancreatitis and confirmed germline mutation of PRSS1)
- Age:
- Person with a family history of PaC: \> 50 years or 10 years before the diagnosis of PaC in the youngest family member (whichever comes first)
- Person with STK11 mutation: \> 35 years or 10 years before the diagnosis of PaC in the youngest family member (whichever comes first)
- Person with CDKN2A mutation: \> 40 years or 10 years before the diagnosis of PaC in the youngest family member (whichever comes first)
- Person with APC, ATM, BRCA1, BRCA2, MLH1, MSH2, MSH6, PMS2, EPCAM, PALB2 or TP53 mutation: \> 45 years or 10 years before the diagnosis of PaC in the youngest family member (whichever comes first)
- Person with hereditary pancreatitis: \> 40 years or 20 years after the 1st attack (whichever comes first)
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (16)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fakultni nemocnice u sv. Anny Coordinator of this site? Confirm its status | Brno | Czechia | Recruiting |
| Fakultni nemocnice Brno Coordinator of this site? Confirm its status | Brno | Czechia | Recruiting |
| Masarykuv onkologicky ustav Coordinator of this site? Confirm its status | Brno | Czechia | Recruiting |
| Nemocnice Ceske Budejovice Coordinator of this site? Confirm its status | České Budějovice | Czechia | Recruiting |
| Fakultni nemocnice Hradec Kralove Coordinator of this site? Confirm its status | Hradec Králové | Czechia | Recruiting |
| Nemocnice Jablonec nad Nisou Coordinator of this site? Confirm its status | Jablonec nad Nisou | Czechia | Not yet recruiting |
| Fakultni nemocnice Olomouc Coordinator of this site? Confirm its status | Olomouc | Czechia | Recruiting |
| Nemocnice Pardubickeho kraje Coordinator of this site? Confirm its status | Pardubice | Czechia | Recruiting |
| Fakultni nemocnice Plzen Coordinator of this site? Confirm its status | Pilsen | Czechia | Recruiting |
| Fakultni nemocnice Kralovske Vinohrady Coordinator of this site? Confirm its status | Prague | Czechia | Recruiting |
| Vseobecna Fakultni Nemocnice Coordinator of this site? Confirm its status | Prague | Czechia | Recruiting |
| Ustredni vojenska nemocnice Coordinator of this site? Confirm its status | Prague | Czechia | Recruiting |
| Fakultni nemocnice Bulovka Coordinator of this site? Confirm its status | Prague | Czechia | Recruiting |
| Institut klinicke a experimentalni mediciny Coordinator of this site? Confirm its status | Prague | Czechia | Recruiting |
| Fakultni Thomayerova nemocnice Coordinator of this site? Confirm its status | Prague | Czechia | Recruiting |
| Masarykova nemocnice v Usti nad Labem Coordinator of this site? Confirm its status | Ústí nad Labem | Czechia | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.